MedPath

Laparoscopic Sleeve Gastrectomy: a Cohort Study

Completed
Conditions
Laparoscopic Sleeve Gastrectomy
Interventions
Procedure: 4-6cm from starting point of gastrectomy to pylorus
Procedure: 2-4cm from starting point of gastrectomy to pylorus
Registration Number
NCT03629808
Lead Sponsor
Beijing Friendship Hospital
Brief Summary

This is a prospective cohort study, which subjects were obese patients requiring LSG surgery. LSG with different gastric resection starting points (2-4cm/4-6 cm from pylorus) as intervention method. The main observation is the incidence and extent of upper gastrointestinal symptoms (such as nausea, vomiting, retching, reflux, difficulty swallowing, etc.).In addition, secondary observations include the excess weight loss (%EWL) and postoperative complications. Aim to investigate the effects of LSG surgery in different starting points of gastric resection on postoperative upper gastrointestinal symptoms.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
138
Inclusion Criteria
  • Patients were accepted for surgery if they satisfied the guidelines of the Society of Chinese Gastroenterological Surgeons [body mass index (BMI) ≥40 kg/m2 or BMI ≥35 kg/m2 with at least one co-morbidity associated with obesity (type 2 diabetes, hypertension, dyslipidemia, obstructive sleep apnea), age between 18 and 60 years, and failure of conservative treatment over 2 years].
  • All patients undergo preoperative upper gastrointestinal (GI) endoscopy.
Exclusion Criteria
  • any patient who had previously been submitted to any type of bariatric surgery;
  • patient currently taking anti-nausea or GERD medications preoperatively;
  • any current smokers;
  • active duodenal/gastric ulcer disease;
  • difficult to treat gastroesophageal reflux disease (GERD) with a large hiatal hernia;
  • previous major gastrointestinal surgery;
  • diagnosed or suspected malignancy;
  • poorly controlled significant medical or psychiatric disorders;
  • disorders such as a medical history of major pathology;
  • can not be able to understand and willing to participate in this registry with signature.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Group1: 4-6cm4-6cm from starting point of gastrectomy to pylorus4-6cm from starting point of gastrectomy to pylorus
Group2: 2-4cm2-4cm from starting point of gastrectomy to pylorus2-4cm from starting point of gastrectomy to pylorus
Primary Outcome Measures
NameTimeMethod
The incidence rate of upper gastrointestinal symptoms after surgery1 year after surgery

We use three scales to evaluate the incidence of upper gastrointestinal symptoms,include the Chinese translation of R-INVR(the Index of Nausea, Vomiting, and Retching)、EAT-10(Validity and Reliability of the Eating Assessment Tool) and GIS(GERD impact serve).These three scales describe postoperative upper gastrointestinal symptoms,which include vomiting, dysphagia,and acid reflux,heartburn.We focus on the incidence rate of the above symptoms in one year after surgery during 1 year.

Visit: Post-op 12 months Visit(±7 Days)

Secondary Outcome Measures
NameTimeMethod
the rate of postoperative complications after surgery1 year after surgery

Postoperative complications including but not limited to: 1, abdominal bleeding; 2, gastrointestinal bleeding; 3, intestinal obstruction; 4, digestive tract leakage 5, anastomotic stenosis / gastric stenosis; 6, death ,etc.

Visit 1: Baseline Visit (Day 0-1) Visit 2: Post-op 3 days Visit Visit 3: Post-op 7 days Visit Visit 4: Post-op 1 month Visit(±3 Days) Visit 5: Post-op 3 months Visit(±7 Days) Visit 6: Post-op 12 months Visit(±7 Days)

The excess weight loss (%EWL) after surgery1 year after surgery

Percent excess weight loss (%EWL), %EWL=\[(initial weight)-(post-op weight)\]/\[(initial weight)-(ideal weight)\] (in which "ideal weight" is defined by the weight corresponding to a BMI of 25 kg/m2).

Visit 1: Baseline Visit (Day 0-1) Visit 2: Post-op 3 days Visit Visit 3: Post-op 7 days Visit Visit 4: Post-op 1 month Visit(±3 Days) Visit 5: Post-op 3 months Visit(±7 Days) Visit 6: Post-op 12 months Visit(±7 Days)

The extent of upper gastrointestinal symptoms after surgery1 year after surgery

We use three scales to evaluate the incidence of upper gastrointestinal symptoms,include the Chinese translation of R-INVR(the Index of Nausea, Vomiting, and Retching)、EAT-10(Validity and Reliability of the Eating Assessment Tool) and GIS(GERD impact serve).These three scales quantify the degree of vomiting, difficulty swallowing, acid reflux, heartburn, etc.We will calculate the extent of the above upper gastrointestinal symptoms at five time points in one year after surgery.

Visit 1: Post-op 3 days Visit Visit 2: Post-op 7 days Visit Visit 3: Post-op 1 month Visit(±3 Days) Visit 4: Post-op 3 months Visit(±7 Days) Visit 5: Post-op 12 months Visit(±7 Days)

Trial Locations

Locations (1)

Beijing Friendship Hospital

🇨🇳

Beijing, Beijing, China

© Copyright 2025. All Rights Reserved by MedPath